Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeffrey Lorne Kadanoff Insider Profile
4 Followers
Jeffrey Lorne Kadanoff, Chief Financial Officer at Knight Therapeutics, holds 86.67K shares in Carebook Technologies Inc (Ticker: TSE:CRBK), holds 168.72K shares in Knight Therapeutics (Ticker: KHTRF). Most recently, Jeffrey Lorne Kadanoff Bought ― shares of Carebook Technologies Inc on May 20, 2022 for an estimated value of 10.00K.
Jeffrey Lorne Kadanoff Knight Therapeutics (KHTRF)Chief Financial Officer
Knight Therapeutics (KHTRF)
Chief Financial Officer
Ranked #79,314 out of 98,042 Corporate Insiders
Profitable Transactions
2 out of 6 Profitable Transactions
Average Return
-19.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeffrey Lorne Kadanoff holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 06, 2016 - Jun 06, 2017
Return:+10.20%
The most profitable trade made by Jeffrey Lorne Kadanoff
Jeffrey Lorne Kadanoff's Trading History
Knight Therapeutics
Sep 20, 2017
Chief Financial Officer
Uninformative Buy
7.09K
$698.49K
Carebook Technologies Inc
May 20, 2022
Senior Officer
Informative Buy
10.00K
C$6.07K
List of latest transactions for each holding click on a transaction to see Jeffrey Lorne Kadanoff's performance on stock
You May Also Like
Jeffrey Lorne Kadanoff insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Lorne Kadanoff?
The percentage of profitable transactions made by Jeffrey Lorne Kadanoff is 33%.
What is the average return per transaction made by Jeffrey Lorne Kadanoff?
The average return per transaction made by Jeffrey Lorne Kadanoff is -19.90%.
What stocks does Jeffrey Lorne Kadanoff hold?
Jeffrey Lorne Kadanoff holds: KHTRF, TSE:CRBK stocks.
What was Jeffrey Lorne Kadanoff’s latest transaction?
Jeffrey Lorne Kadanoff latest transaction was an Informative Buy of C$10.00K.
What was Jeffrey Lorne Kadanoff's most profitable transaction?
Jeffrey Lorne Kadanoff’s most profitable transaction was an Informative Buy of KHTRF stock on June 6, 2016. The return on the trade was 10.20%.
What is Jeffrey Lorne Kadanoff's role in Knight Therapeutics?
Jeffrey Lorne Kadanoff's role in Knight Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.